Efficacy of clarithromycin in patients with mild COVID-19 pneumonia not receiving oxygen administration: protocol for an exploratory, multicentre, open-label, randomised controlled trial (CAME COVID-19 study)

Guardado en:

Detalles Bibliográficos
Autores principales:	Hiroshi Mukae, Noriho Sakamoto, Naoki Hosogaya, Kazuko Yamamoto, Haruo Yoshida, Kazuhiro Yatera, Koichi Izumikawa, Katsunori Yanagihara
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Medicine R
Acceso en línea:	https://doaj.org/article/8f80414f91374a768e8951cffc55ca4a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:8f80414f91374a768e8951cffc55ca4a
record_format	dspace
spelling	oai:doaj.org-article:8f80414f91374a768e8951cffc55ca4a2021-11-14T02:00:05ZEfficacy of clarithromycin in patients with mild COVID-19 pneumonia not receiving oxygen administration: protocol for an exploratory, multicentre, open-label, randomised controlled trial (CAME COVID-19 study)10.1136/bmjopen-2021-0533252044-6055https://doaj.org/article/8f80414f91374a768e8951cffc55ca4a2021-09-01T00:00:00Zhttps://bmjopen.bmj.com/content/11/9/e053325.fullhttps://doaj.org/toc/2044-6055Hiroshi MukaeNoriho SakamotoNaoki HosogayaKazuko YamamotoHaruo YoshidaKazuhiro YateraKoichi IzumikawaKatsunori YanagiharaBMJ Publishing GrouparticleMedicineRENBMJ Open, Vol 11, Iss 9 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R
spellingShingle	Medicine R Hiroshi Mukae Noriho Sakamoto Naoki Hosogaya Kazuko Yamamoto Haruo Yoshida Kazuhiro Yatera Koichi Izumikawa Katsunori Yanagihara Efficacy of clarithromycin in patients with mild COVID-19 pneumonia not receiving oxygen administration: protocol for an exploratory, multicentre, open-label, randomised controlled trial (CAME COVID-19 study)
format	article
author	Hiroshi Mukae Noriho Sakamoto Naoki Hosogaya Kazuko Yamamoto Haruo Yoshida Kazuhiro Yatera Koichi Izumikawa Katsunori Yanagihara
author_facet	Hiroshi Mukae Noriho Sakamoto Naoki Hosogaya Kazuko Yamamoto Haruo Yoshida Kazuhiro Yatera Koichi Izumikawa Katsunori Yanagihara
author_sort	Hiroshi Mukae
title	Efficacy of clarithromycin in patients with mild COVID-19 pneumonia not receiving oxygen administration: protocol for an exploratory, multicentre, open-label, randomised controlled trial (CAME COVID-19 study)
title_short	Efficacy of clarithromycin in patients with mild COVID-19 pneumonia not receiving oxygen administration: protocol for an exploratory, multicentre, open-label, randomised controlled trial (CAME COVID-19 study)
title_full	Efficacy of clarithromycin in patients with mild COVID-19 pneumonia not receiving oxygen administration: protocol for an exploratory, multicentre, open-label, randomised controlled trial (CAME COVID-19 study)
title_fullStr	Efficacy of clarithromycin in patients with mild COVID-19 pneumonia not receiving oxygen administration: protocol for an exploratory, multicentre, open-label, randomised controlled trial (CAME COVID-19 study)
title_full_unstemmed	Efficacy of clarithromycin in patients with mild COVID-19 pneumonia not receiving oxygen administration: protocol for an exploratory, multicentre, open-label, randomised controlled trial (CAME COVID-19 study)
title_sort	efficacy of clarithromycin in patients with mild covid-19 pneumonia not receiving oxygen administration: protocol for an exploratory, multicentre, open-label, randomised controlled trial (came covid-19 study)
publisher	BMJ Publishing Group
publishDate	2021
url	https://doaj.org/article/8f80414f91374a768e8951cffc55ca4a
work_keys_str_mv	AT hiroshimukae efficacyofclarithromycininpatientswithmildcovid19pneumonianotreceivingoxygenadministrationprotocolforanexploratorymulticentreopenlabelrandomisedcontrolledtrialcamecovid19study AT norihosakamoto efficacyofclarithromycininpatientswithmildcovid19pneumonianotreceivingoxygenadministrationprotocolforanexploratorymulticentreopenlabelrandomisedcontrolledtrialcamecovid19study AT naokihosogaya efficacyofclarithromycininpatientswithmildcovid19pneumonianotreceivingoxygenadministrationprotocolforanexploratorymulticentreopenlabelrandomisedcontrolledtrialcamecovid19study AT kazukoyamamoto efficacyofclarithromycininpatientswithmildcovid19pneumonianotreceivingoxygenadministrationprotocolforanexploratorymulticentreopenlabelrandomisedcontrolledtrialcamecovid19study AT haruoyoshida efficacyofclarithromycininpatientswithmildcovid19pneumonianotreceivingoxygenadministrationprotocolforanexploratorymulticentreopenlabelrandomisedcontrolledtrialcamecovid19study AT kazuhiroyatera efficacyofclarithromycininpatientswithmildcovid19pneumonianotreceivingoxygenadministrationprotocolforanexploratorymulticentreopenlabelrandomisedcontrolledtrialcamecovid19study AT koichiizumikawa efficacyofclarithromycininpatientswithmildcovid19pneumonianotreceivingoxygenadministrationprotocolforanexploratorymulticentreopenlabelrandomisedcontrolledtrialcamecovid19study AT katsunoriyanagihara efficacyofclarithromycininpatientswithmildcovid19pneumonianotreceivingoxygenadministrationprotocolforanexploratorymulticentreopenlabelrandomisedcontrolledtrialcamecovid19study
_version_	1718430088404402176

Efficacy of clarithromycin in patients with mild COVID-19 pneumonia not receiving oxygen administration: protocol for an exploratory, multicentre, open-label, randomised controlled trial (CAME COVID-19 study)

Ejemplares similares